Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal … – MarketWatch (press release)

Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal …
MarketWatch (press release)
In addition, Array initiated new clinical trials for two proprietary anti-inflammatory drugs: ARRY-797 for pain and ARRY-502 for asthma. ARRY-797 is being tested in a 150-patient Phase 2 chronic pain trial in osteoarthritis (OA) patients with top-line …

and more »